A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer

NCT05141721 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

700

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Neoplasms

Interventions

DRUG: GRT-C901
DRUG: GRT-R902
DRUG: Atezolizumab
DRUG: Ipilimumab
DRUG: Fluoropyrimidine plus leucovorin
DRUG: Bevacizumab

Sponsor

Seattle Project Corporation